NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
| Market Cap | 9.66M-82.5% |
| Revenue (ttm) | n/a+50.8% |
| Net Income | n/a-34.0% |
| EPS | n/a-151.8% |
| Shares Out | 8.70M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 115,844 |
| Open | 1.12 |
| Previous Close | 1.13 |
| Day's Range | 1.09 - 1.16 |
| 52-Week Range | 0.96 - 6.54 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 5.00(+350.45%) |
| Earnings Date | n/a |
NEUROONE MEDICAL TECHNOLOGIES Corp has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About NMTC
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$NMTC stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in NMTC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NMTC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NMTC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
NMTC Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Upfront payment | $3.00M | 20.04% |
| Aggregate transaction price | $3.00M | 20.04% |
| Fee payment | $3.00M | 20.04% |
| License revenue | $3.00M | 20.04% |
| Product revenue | $1.97M | 13.18% |
| Additional payment | $1.00M | 6.68% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New NMTC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NMTC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NMTC
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $433.39K |
| VXFVanguard Extended Market ETF | $153.20K |
| IWCiShares Micro-Cap ETF | $25.31K |
Estimated from each fund’s disclosed top holdings × AUM
NMTC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from NMTC’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score